Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.60    1.05 (16.03%)
Bid:
7.20
Ask:
8.00
Spread: 0.80 (11.111%)
Market Cap: £9.08m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Half Yearly Report

13 Dec 2012 07:00

RNS Number : 4158T
Marechale Capital PLC
13 December 2012
 



 

13 December 2012

 

Marechale Capital plc

("Marechale" or the "Company")

 

Interim Results

 

Marechale Capital plc today announces its unaudited interim results for the six months ended 30 September 2012.

 

Chairman's Statement

 

Similar to last year, we report an Interim loss, albeit higher than budget. The first six months of the current year have been challenging because, whilst Marechale has a steadily increasing number of growing businesses and funds as clients that it advises and acts for, the economic sentiment generally, and uncertainty in the equity markets in particular, has made fundraising difficult with projects taking longer to complete.

 

Marechale's revenues are often unevenly spread on a month to month basis, and, as in previous years, revenue is expected to be heavily weighted to the second half of the financial year from September to the end of March. Therefore, reporting a half year loss is not to be unexpected at this point in the year.

 

However, I am able to report that the Company has successfully completed a number of transactions and we also have a healthy pipeline of projects; more details about these projects are available on our website: www.marechalecapital.com.

 

Marechale operates as a corporate finance advisory and capital fund raising business focusing on fundraising for growth companies and funds in three sectors in which the team have a long term track record: Leisure and Retail, Renewable Energy and Online Exchanges.

 

Marechale helps management teams to finance or refinance in two key areas of activity: Growth Capital private equity transactions for more established businesses, and Development Capital, fundraising for smaller growth companies, the latter typically being Enterprise Investment Scheme (EIS) qualifying. As part of Marechale's success fee, the Company secures warrants or equity on most of its projects, so shareholders have the opportunity to share in the potential significant upside of the equity value in these businesses. We continue to build these investments in many of our advisory clients which the Board expect to grow in value over the next 2-3 years.

 

Whilst market conditions are still challenging, and we remain cautious about the immediate outlook, there is a good pipeline of businesses seeking funding. Deal flow is picking up in December and, at fourteen clients, we have our highest number of engaged corporate finance projects to date. This includes launching a new £30m Renewable Energy EIS Fund, the first fund to which Marechale is acting as on-going investment adviser, and two other new EIS and VCT fund launches in the Leisure and Social Impact sectors. There is an appetite amongst our investor relationships to invest in high quality investment opportunities and this gives us confidence in the second half of the year.

 

Marechale has a number of Associates who are specialists in particular sectors, with whom we work on specific transactions under a fee sharing arrangement; some of these Associates have indicated that they wish to purchase shares in the Company, and we plan to issue new shares to some of these people following the announcement of these Interims.

 

We hope to give you a more positive update on Marechale after the March 2013 year end.

 

Mark Warde-Norbury

Chairman

13 December 2012

 

 

 

For further information please contact:

 

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn

 

Tel: +44 (0)20 7628 5582

Smith & Williamson Corporate Finance

Azhic Basirov / David Jones

 

Tel: +44 (0)20 7131 4000

 

Marechale Capital plc

Income Statement (unaudited)

Six months ended 30 September 2012

30 Sept

30 Sept

2012

2011

£

£

Revenue

140,682

237,319

Cost of sales

(32,211)

(25,940)

Gross profit

108,471

211,379

Administrative expenses

(278,015)

(297,235)

Operating (loss)/profit

(169,544)

(85,856)

Investment revenues

0

39

Other gains and losses

13,500

0

Loss/ profit before tax

(156,044)

(85,817)

Corporation tax charge

0

0

(Loss)/ profit for the period

(156,044)

(85,817)

 

Earnings per share (Basic and diluted)

52,437,410 shares (2011: 52,437,410)

(0.30p)

 

(0.16p)

 

 

Balance Sheet (unaudited)

As at 30 September 2012

30 Sept

30 Sept

2012

2011

£

£

Current assets

Available for sale investments

101,238

76,351

Trading investments

1,600

28,125

Trade and other receivables

129,176

41,608

Cash and cash equivalents

147,715

284,870

Total current assets

379,729

430,954

Current liabilities

Trade and other payables

(53,721)

(47,771)

Corporation tax

0

0

Total current liabilities

(53,721)

(47,771)

Net assets

326,007

383,183

Equity

Share capital

2,421,871

2,421,871

Share premium account

1,227,452

1,227,452

Revaluation reserves

16,989

21,602

Other reserves

(50,254)

(50,254)

Retained earnings

(3,290,051)

(3,237,488)

Total equity

326,007

383,183

 

Cash Flow Statement (unaudited)

Six months ended 30 September 2012

30 Sept

30 Sept

2012

2011

£

£

Net cash from operating activities

Operating (loss)/ profit

(169,544)

(85,855)

Operating cash flows before movements in working capital

(169,544)

(85,855)

Movement in working capital

Decrease in receivables

22,918

40,874

(Decrease)in payables

(908)

(751)

23,826

40,123

Operating cash flow

(147,534)

(45,732)

Investment activities

Interest receivable

0

38

Proceeds on disposal of trading investments

20,000

-

Proceeds on disposal of available for sale investments

(500)

-

Expenditure on tangible fixed assets

0

-

Expenditure on trading investments

(35,000)

(11,500)

Cash flow from investing activities

(15,500)

(11,462)

Financing

Issue of share capital

0

100,000

Interest payable

0

0

Cash flow from financing activities

0

100,000

Net increase/(decrease) in cash and cash equivalents

(163,034)

42,806

Cash and cash equivalents at start of period

310,749

242,064

Cash and cash equivalents at end of period

147,715

284,870

(Decrease)/ increase in cash and cash equivalents

(163,034)

42,806

 

 

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior periods being reported on the same basis.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR VLLFFLLFBFBX
Date   Source Headline
2nd Oct 20207:00 amRNSChange of Adviser
28th Sep 20201:20 pmRNSPosting of Annual Report and Notice of AGM
25th Aug 202010:39 amRNSHolding(s) in Company
24th Aug 20207:00 amRNSFinal Results
10th Aug 202010:03 amRNSHolding(s) in Company
7th Aug 20201:05 pmRNSHolding(s) in Company
6th Aug 202010:09 amRNSHolding(s) in Company
5th Aug 202011:35 amRNSHolding(s) in Company
4th Aug 20201:03 pmRNSHolding(s) in Company
30th Jul 20204:40 pmRNSSecond Price Monitoring Extn
30th Jul 20204:35 pmRNSPrice Monitoring Extension
17th Jan 20203:31 pmRNSHolding(s) in Company
12th Dec 20193:08 pmRNSHalf-year Report
24th Sep 201912:16 pmRNSHolding(s) in Company
23rd Sep 20193:38 pmRNSResult of AGM
2nd Sep 20192:46 pmRNSPosting of Annual Report and Notice of AGM
29th Aug 20193:48 pmRNSFinal Results
12th Jul 20191:45 pmRNSBoard Change
1st May 201912:39 pmRNSTrading Statement
25th Jan 201910:16 amRNSInterim Results
12th Dec 20187:00 amRNSChange of Adviser
28th Nov 20185:18 pmRNSChange of Adviser
8th Nov 20183:16 pmRNSDirector/PDMR Shareholding
4th Oct 20182:11 pmRNSResult of AGM
13th Sep 20189:50 amRNSPosting of Annual Report and Notice of AGM
21st Aug 20186:13 pmRNSHolding(s) in Company
21st Aug 201811:35 amRNSFinal Results
5th Jul 20181:55 pmRNSHolding(s) in Company
16th Apr 20182:04 pmRNSHolding(s) in Company
7th Mar 20182:19 pmRNSDirector/PDMR Shareholding
29th Jan 20187:00 amRNSInterim Results
25th Jan 20182:25 pmRNSHolding(s) in Company
8th Dec 201712:01 pmRNSHolding(s) in Company
9th Nov 20175:01 pmRNSTrading Update
14th Sep 201710:57 amRNSResult of AGM
18th Aug 20173:59 pmRNSPosting of Annual Report and Notice of AGM
14th Aug 201712:20 pmRNSDirector/PDMR Shareholding
27th Jul 20177:00 amRNSFinal Results
25th Jan 20171:50 pmRNSCapital reduction update
22nd Dec 201611:37 amRNSDirector/PDMR Shareholding
16th Dec 20167:00 amRNSHalf-year Report
15th Sep 20161:13 pmRNSDirector/PDMR Shareholding
14th Sep 201612:54 pmRNSResult of AGM
24th Aug 20164:36 pmRNSPosting of Annual Report & Notice of AGM
25th Jul 20167:00 amRNSFinal Results
4th May 201611:42 amRNSStmnt re Share Price Movement
20th Jan 20163:14 pmRNSDirectorate Change
19th Jan 20161:11 pmRNSStmnt re Share Price Movement
17th Dec 20157:00 amRNSHalf Yearly Report
19th Nov 20155:30 pmRNSNorthfield UK Solar Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.